Taxol in the management of cancers of the breast and the ovary

被引：40

作者：

Khayat, D ^{[1
]}

Antoine, EC ^{[1
]}

Coeffic, D ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Dept Med Oncol, F-75013 Paris, France

来源：

CANCER INVESTIGATION | 2000年 / 18卷 / 03期

关键词：

D O I：

10.3109/07357900009031828

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：242 / 260

页数：19

共 123 条

[1]

ACUNA LR, 1997, P AN M AM SOC CLIN, V16, pA188

[2]

ANELLI A, 1997, P AN M AM SOC CLIN, V16, pA158

[3] A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group Study [J].

Aravantinos, G ;

Skarlos, DV ;

Kosmidis, P ;

Athanassiades, A ;

Bafaloukos, D ;

Giannakakis, T ;

Karpathios, S ;

Fountzilas, G .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) :160-163

[4]

ARAVANTINOS G, 1997, P AN M AM SOC CLIN, V16, pA168

[5]

ATHANASSIOU A, 1994, P AN M AM SOC CLIN, V13, P870

[6]

BERRY J, 1995, P AN M AM SOC CLIN, V14, P136

[7] Paclitaxel (Taxol) monotherapy in the treatment of progressive and recurrent ovarian carcinoma after platinum-based chemotherapy [J].

Blom, R ;

Palm, N ;

Simonsen, E .

ACTA ONCOLOGICA, 1996, 35 (06) :733-736

[8]

Bolis G, 1995, SEMIN ONCOL, V22, P32

[9]

BOLIS G, 1997, SEMIN ONCOL, V24, P25

[10]

Breier S, 1997, P AN M AM SOC CLIN, V16, pa568

← 1 2 3 4 5 6 7 8 9 10 →